Malin Fagerås - Concepedia

Author

Malin Fagerås

AstraZeneca (Sweden)

Also Known As

M Fageras, M Fagerås, M. Fagerås, Magdalena Bilińska-Izydorczyk, Malin Fageras, Malin Fagerås, Ruth Tal-Singer

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)AstraZeneca (United Kingdom)University of Colorado Denver AstraZeneca (United States)Linköping University

About

Malin Fagerås is an author at AstraZeneca (Sweden) specializing in medicine, public health, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	856
2	Public Health	3	3	750
3	Epidemiology	2	2	694
4	Allergy	1	1	59
5	Nutrition	1	1	56

Malin Fagerås

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials Mona Bafadhel, Stefan Peterson, Miguel A De Blas, The Lancet Respiratory Medicine EpidemiologyInflammatory Lung DiseaseExacerbation RiskAdvanced Lung DiseaseRandomised Trials	2018	428
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease Fernando J. Martínez, MeiLan K. Han, James P. Allinson, American Journal of Respiratory and Critical Care Medicine Pulmonary CareInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationTobacco Control	2018	266
Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation Catrin Furuhjelm, Kristina Warstedt, Malin Fagerås, Pediatric Allergy and Immunology	2011	159
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults Luis Pérez de Llano, Ghislaine Scélo, Trung N. Tran, American Journal of Respiratory and Critical Care Medicine	2024	85
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Monica Kraft, Guy Brusselle, J. Mark FitzGerald, European Respiratory Journal	2021	63
Slow Salivary Secretory IgA Maturation May Relate to Low Microbial Pressure and Allergic Symptoms in Sensitized Children Malin Fagerås, Sara Tomičić, Tiia Voor, Pediatric Research AllergyAllergic SymptomsOral CavityPathogenesisPediatrics	2011	59
The Effects of Omega-3 Fatty Acid Supplementation in Pregnancy on Maternal Eicosanoid, Cytokine, and Chemokine Secretion Kristina Warstedt, Catrin Furuhjelm, Karel Duchén, Pediatric Research NutritionOmega-3 Fatty AcidMaternal EicosanoidGynecologyFetal Health	2009	56
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials Anne L. Fuhlbrigge, Thomas Bengtsson, Stefan Peterson, The Lancet Respiratory Medicine AsthmaClinical TrialsNovel EndpointClinical DevelopmentPost-hoc Analysis	2017	47
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial Naimish Patel, Danen Cunoosamy, Malin Fagerås, International Journal of COPD	2018	47
Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry Andrew I. Ritchie, Gavin C. Donaldson, Eric A. Hoffman, American Journal of Respiratory and Critical Care Medicine	2024	46

Page 1